We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio. In the last five years alone, we have completed more than 200 projects related to portfolio strategy.

Therapeutic Area and Franchise Strategy

Our goal is to help customers enter key areas with confidence. Within oncology alone, we bring portfolio planning experience in 20+ tumor types across a broad spectrum of mechanistic classes. Offerings include:

  • Situation Assessment (Current and Future)
  • Vision and Goals
  • Asset Identification, Assessment, and Prioritization
  • Disease / Therapeutic Area Strategy

Licensing and Business Development Strategy

Blue Matter provides support to clients that are seeking to acquire or in-license assets and those that are seeking to out-license. We help inform clinical development and licensing decisions and optimize investments across the portfolio.

  • Asset Evaluation
  • Trade-Off Decisions / Investment Recommendations


Contact Us to learn more.